Predictive testing and clinical trials in Huntington's disease: An ethical analysis
- PMID: 29205501
- PMCID: PMC5854324
- DOI: 10.1002/mds.27247
Predictive testing and clinical trials in Huntington's disease: An ethical analysis
Keywords: Huntington's disease; clinical trial design; ethics; neurodegenerative diseases; predictive testing.
Conflict of interest statement
Cristina Sampaio has management functions within CHDI. Jamie Levey has management functions within CHDI and the European Huntington’s Disease Network. Robert Klitzman has no conflicts of interest to report.
Figures
Similar articles
-
Special Issue: DNA Repair and Somatic Repeat Expansion in Huntington's Disease.J Huntingtons Dis. 2021;10(1):3-5. doi: 10.3233/JHD-219001. J Huntingtons Dis. 2021. PMID: 33554921 Free PMC article. No abstract available.
-
Is Huntington's disease on the threshold of a new era in treatment?Neurodegener Dis Manag. 2019 Oct;9(5):255-258. doi: 10.2217/nmt-2019-0015. Neurodegener Dis Manag. 2019. PMID: 31580228 No abstract available.
-
Huntington's disease: 4 big questions.Nature. 2018 May;557(7707):S48. doi: 10.1038/d41586-018-05180-3. Nature. 2018. PMID: 29844555 No abstract available.
-
Interrupting sequence variants and age of onset in Huntington's disease: clinical implications and emerging therapies.Lancet Neurol. 2020 Nov;19(11):930-939. doi: 10.1016/S1474-4422(20)30343-4. Lancet Neurol. 2020. PMID: 33098802 Review.
-
Huntington's disease: how does huntingtin, an anti-apoptotic protein, become toxic?Pathol Biol (Paris). 2004 Jul;52(6):338-42. doi: 10.1016/j.patbio.2003.06.004. Pathol Biol (Paris). 2004. PMID: 15261377 Review.
Cited by
-
Perceptions about Research Participation among Individuals at Risk and Individuals with Premanifest Huntington's Disease: A Survey Conducted by the European Huntington Association.J Pers Med. 2021 Aug 20;11(8):815. doi: 10.3390/jpm11080815. J Pers Med. 2021. PMID: 34442459 Free PMC article.
-
Positive Attitudes and Therapeutic Misconception Around Hypothetical Clinical Trial Participation in the Huntington's Disease Community.J Huntingtons Dis. 2019;8(4):421-430. doi: 10.3233/JHD-190382. J Huntingtons Dis. 2019. PMID: 31594242 Free PMC article.
-
Long-Term Health Outcomes of Huntington Disease and the Impact of Future Disease-Modifying Treatments: A Decision-Modeling Analysis.Neurol Clin Pract. 2024 Oct;14(5):e200340. doi: 10.1212/CPJ.0000000000200340. Epub 2024 Aug 15. Neurol Clin Pract. 2024. PMID: 39161748 Free PMC article.
References
-
- Levin BC, Richie KL, Jakupciak JP. Advances in Huntington's disease diagnostics: development of a standard reference material. Expert Rev Mol Diagn. 2006;6(4):587–596. - PubMed
-
- MacLeod R, Tibben A, Frontali M, et al. Recommendations for the predictive genetic test in Huntington's disease. Clin Genet. 2013;83(3):221–231. - PubMed
-
- Tabrizi SJ, Scahill RI, Owen G, et al. Predictors of phenotypic progression and disease onset in premanifest and early-stage Huntington's disease in the TRACK-HD study: analysis of 36-month observational data. Lancet Neurol. 2013;12(7):637–649. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical